新型口服抗凝血剂在心房颤动患者中胃肠道出血和颅内出血的风险分析: 系统回顾和网络meta 分析
W Xu, S Hu, T Wu, AW Xu, AS Hu… - Journal of Zhejiang …, 2017 - jzus.zju.edu.cn
… ) and dabigatran 110 … (apixaban 5 mg) and ICH (apixaban 5 mg, dabigatran 110 mg,
and edoxaban 30 mg). Conclusions: Bayesian network meta-analysis of treatment of non-valvular …
and edoxaban 30 mg). Conclusions: Bayesian network meta-analysis of treatment of non-valvular …
Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long‐term results: 合并心房颤动的糖尿病患者通过左心耳封堵术 …
R Litwinowicz, M Bartus, P Ceranowicz… - Journal of …, 2019 - Wiley Online Library
… The results of the present study suggest that LAAO in AF patients with DM has similar safety
endpoints and long-term efficacy as LAAO in the general population, and has similar stroke …
endpoints and long-term efficacy as LAAO in the general population, and has similar stroke …
[PDF][PDF] 新型口服抗凝剂对比华法林在80 岁以上高龄非瓣膜性房颤患者中疗效和安全性的Meta 分析
张梦迪， 谢艳芳， 葛永彬 - 医药导报, 2023 - yydbzz.com
… 华法林在预防 非瓣膜性房颤(non-valvular atrial fibrillationꎬNVAF)患 者脑卒中方面疗效较为显著
[8] … Cardiovascularꎬ bleedingꎬand mortality risks of dabigatran in asians with nonvalvular …
[8] … Cardiovascularꎬ bleedingꎬand mortality risks of dabigatran in asians with nonvalvular …
[HTML][HTML] 直接口服抗凝剂在老年非瓣膜性房颤抗凝治疗有效性与安全性方面的最新进展
钟少正， 袁忠明 - Advances in Clinical Medicine, 2022 - hanspub.org
… with non-valvular AF, age is an independent risk factor for atrial fibrillation. Evaluating the
effectiveness and safety of … were superior to warfarin in terms of effectiveness and safety. By …
effectiveness and safety of … were superior to warfarin in terms of effectiveness and safety. By …
合并慢性肾脏疾病的心房颤动患者的治疗
张涛， 杨艳敏 - 中华心脏与心律电子杂志, 2022 - zhxzyxldzzz.cma-cmc.com.cn
… Efficacy and safety of Apixaban compared with Warfarin in patients with atrial fibrillation
in relation to renal function over time: Insights from the ARISTOTLE randomized clinical trial[J]. …
in relation to renal function over time: Insights from the ARISTOTLE randomized clinical trial[J]. …
心房颤动患者使用新型口服抗凝药有效性和安全性的网状Meta 分析
霍礼超， 李梦丽， 宋明惠， 张彦霞， 薛鹏龙， 乔成栋 - 中国全科医学, 2019 - chinagp.net
… Dabigatran versus warfarin for the prevention of stroke in Chinese patients with nonvalvular
atrial fibrillation:Chinese … Chinese Journal of Cardiology,2016,44(11):929-934. DOI:10.3760/…
atrial fibrillation:Chinese … Chinese Journal of Cardiology,2016,44(11):929-934. DOI:10.3760/…
中文版/CHINESE EDITION
C Collet, Y Miyazaki - 2019 - jacc.org
… by the Chinese translator and revised by the Chinese Editor-… Editor-in-Chief of the Chinese
edition in relation to the use of … the Editor-in-Chief of the Chinese edition for any injury and/or …
edition in relation to the use of … the Editor-in-Chief of the Chinese edition for any injury and/or …
新型口服抗凝药在慢性肾病患者中的应用
汪秀衡， 吴洁， 胡恒境 - 基础医学与临床, 2020 - journal11.magtechjournal.com
… Thromboembolicꎬ bleedingꎬ and mortality risks of rivaroxaban and dabigatran in asians
with nonvalvular atrial fibrillation[J]. J Am Coll Cardiolꎬ 2016ꎬ 68:1389-1401. [14] Ha JTꎬ …
with nonvalvular atrial fibrillation[J]. J Am Coll Cardiolꎬ 2016ꎬ 68:1389-1401. [14] Ha JTꎬ …
左心耳封堵术与口服抗凝药物应用于心房颤动患者有效性及安全性的meta 分析
任艳霞， 安智晶， 张得梅， 郭雪娅 - 上海交通大学学报(医学版), 2021 - xuebao.shsmu.edu.cn
… Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation:
the rivaroxaban … of atrial fibrillation in an elderly Chinese population: a prospective study[J]. …
the rivaroxaban … of atrial fibrillation in an elderly Chinese population: a prospective study[J]. …
新型口服抗凝药物在非瓣膜性心房颤动患者中的应用及挑战
刘岳， 任怡荣， 朱火兰， 汪芳 - 中国全科医学, 2020 - chinagp.net
… Dabigatran versus warfarin:effects on ischemic and hemorrhagic strokes and bleeding in
Asians and non-Asians … tests in patients with nonvalvular atrial fibrillation under dabigatran and …
Asians and non-Asians … tests in patients with nonvalvular atrial fibrillation under dabigatran and …